Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

    Feb 7, 2025, 08:24 AM by
    A clinical trial for people living with the life-threatening lung condition Progressive Pulmonary Fibrosis (PPF) is using deep learning imaging technology to evaluate a new treatment to tackle the condition for the first time.
    Full story
  • Crystal Ball: At JP Morgan, Companies Predict Trump Administration Impacts

    Feb 6, 2025, 01:00 AM by User Not Found
    Bio-IT World| Market questions always arise with the changing of presidential administration in the United States, though this year’s uncertainty seems a bit heightened. Expected outlooks to NIH funding and other regulatory and even Department of Government Efficiencies (DOGE) changes came up in analyst questions after some of the presentations at the J.P. Morgan Healthcare Conference last month.
    Full story
  • Sapio Sciences Selected by LabConnect to Transform Laboratory Operations

    Feb 5, 2025, 07:47 AM by
    Sapio Sciences today announced that LabConnect has chosen Sapio LIMS (Laboratory Information Management System) to digitally transform complex research workflows, streamline sample tracking, and enhance data management.
    Full story
  • 10X Genomics at JPM: New Products, New Sales Team, New Markets

    Feb 5, 2025, 01:00 AM by User Not Found
    Bio-IT World | 10X Genomics launched a spate of new products in 2024 in both their single cell and spatial areas. “Our view is that eventually, every relevant sample will need to be analyzed with single cell and spatial context,” said Serge Saxonov, 10X CEO and co-founder, in his 2025 J.P. Morgan Healthcare Conference presentation.
    Full story
  • Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability

    Feb 4, 2025, 09:01 AM by
    Synexa Life Sciences has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility.
    Full story
  • Recursion at JPM: Exscientia Merger and the Coming Virtual Cell

    Feb 4, 2025, 01:00 AM by User Not Found
    Bio-IT World | Chris Gibson, CEO of Recursion, gave the company update last month at the 2025 J.P. Morgan Healthcare Conference. Gibson gave updates on several Recursion pipeline programs for indications including precision oncology, rare disease, and other indications. He also gave updates on the merger with Exscientia and the coming virtual cell.
    Full story
  • Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure

    Feb 3, 2025, 09:53 AM by
    Sapio Sciences today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules. By deploying Sapio’s unified informatics platform, including Sapio LIMS and Sapio ELN, Schrödinger is transforming its recently acquired wet lab operations, integrating data, and streamlining workflows.
    Full story
  • ActiGraph and Hyfe announce availability of new digital health tool for cough monitoring

    Feb 3, 2025, 09:53 AM by
    ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.
    Full story
  • The MAP Group Unites Three Companies Under One New Brand Name, Kintiga

    Feb 3, 2025, 09:53 AM by
    The MAP Group unifies under new brand name
    Full story
  • Ambience Healthcare Joins athenahealth’s Marketplace Program to Support Clinicians with AI-assisted Documentation, Point of Care CDI & Coding, and Care Coordination

    Feb 3, 2025, 09:53 AM by
    Full story
  • Endor Labs Empowers Organizations to Discover and Govern Open Source Artificial Intelligence Models Used in Applications

    Feb 3, 2025, 09:53 AM by
    Endor Labs, the leader in open source software security, today announced a brand new feature in the company’s signature platform enabling organizations to discover the AI models already in use across their applications, and to set and enforce security policies over which models are permitted. Endor Labs AI Model Discovery directly addresses three critical use cases: It enables application security professionals to discover local open source AI models being used in their application code; evaluate risks from those models; and enforce organization-wide policies related to AI model curation and usage. It even goes a step further with automated detection, warning.
    Full story
  • DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration

    Feb 3, 2025, 09:53 AM by
    DNAnexus and Veeva announced an agreement to help advance global regulatory collaboration. The integrated solution will allow users to establish secure collaboration zones with international agencies to share data for regulatory review, validation, and analysis.
    Full story
  • Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences

    Feb 3, 2025, 09:53 AM by
    Zymo Research is proud to introduce the Master the Microbiome Grant, a global initiative dedicated to advancing research in microbiomics, metagenomics, and microbial sciences.
    Full story
  • Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

    Feb 3, 2025, 09:53 AM by
    Full story
  • Redefining Storage to Enable Digital Twins

    Jan 30, 2025, 01:00 AM by User Not Found
    Bio-IT World | While the concept of digital twins is similar in life sciences to manufacturing, human bodies are significantly more complex than industrial machines and systems, amplifying the challenges surrounding data generation, management, and analysis. Making effective use of the data required to advance digital twin research creates immense infrastructure challenges.
    Full story
  • Follow the Money: Obesity, COPD, Universal AI for Biology

    Jan 29, 2025, 01:00 AM by User Not Found
    Bio-IT World | January saw new company launches in COPD and small molecules, as well as investments targeting genetic engineering, epigenome editing, regenerative medicine, and more.
    Full story
  • GSK’s $1B Acquisition, Roche Licenses Gene Therapy, New Products, More

    Jan 28, 2025, 01:00 AM by User Not Found
    Bio-IT World | 23andMe launches a new research offering after mass resignation by their board, new multi-omics tool from Enhanc3D Genomics, Absci and Owkin announce an AI partnership, a new cloud-based vivarium platform from Charles River, and more.
    Full story
  • Radio Frequencies Show Potential in Treating Alzheimer’s Disease

    Jan 23, 2025, 01:00 AM by User Not Found
    Bio-IT World | Through a fortunate stroke of serendipity 15 years ago, researchers experimenting with a mouse model of Alzheimer’s disease found that radio frequency (RF) energy could improve cognitive health. It was not unlike the discovery of penicillin based on the unexpected appearance of a bacteria-killing mold in a petri dish.
    Full story
  • Mount Sinai Develops AI Prediction Tool for Cancer Patient Response to ICI Therapy

    Jan 22, 2025, 01:00 AM by User Not Found
    Bio-IT World | Researchers at the Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), have developed SCORPIO, an artificial intelligence (AI) tool that can predict how well patients with cancer will respond to immune checkpoint inhibitor (ICI) therapy by analyzing routine blood tests and clinical data.
    Full story
  • PacBio at JPM: Portfolio Development, LDTs

    Jan 21, 2025, 01:00 AM by User Not Found
    Bio-IT World | PacBio’s president Christian Henry gave the sequencing company’s 43rd Annual J.P. Morgan Healthcare Conference address last week. And while Oxford Nanopore and Illumina both doubled down on proteomics and a multi-omic future, Henry stayed focus on PacBio’s mission to enable the promise of genomics to better human health.
    Full story
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16 (current)
  • 17
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy